Broomé U - Search Results

1

Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.

Boberg KM, Schrumpf E, Bergquist A, Broomé U, Pares A, Remotti H, Schjölberg A, Spurkland A, Clausen OP. Boberg KM, et al. Among authors: broome u. J Hepatol. 2000 Mar;32(3):374-80. doi: 10.1016/s0168-8278(00)80386-4. J Hepatol. 2000. PMID: 10735605

2

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.

Boberg KM, Rocca G, Egeland T, Bergquist A, Broomé U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Among authors: broome u. Hepatology. 2002 Mar;35(3):652-7. doi: 10.1053/jhep.2002.31872. Hepatology. 2002. PMID: 11870380

3

Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.

Brandsaeter B, Isoniemi H, Broomé U, Olausson M, Bäckman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Kirkegaard P, Friman S, Bjøro K. Brandsaeter B, et al. Among authors: broome u. J Hepatol. 2004 May;40(5):815-22. doi: 10.1016/j.jhep.2004.01.002. J Hepatol. 2004. PMID: 15094230

4

Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis?

Bergquist A, Tribukait B, Glaumann H, Broomé U. Bergquist A, et al. Among authors: broome u. J Hepatol. 2000 Dec;33(6):873-7. doi: 10.1016/s0168-8278(00)80117-8. J Hepatol. 2000. PMID: 11131447

5

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.

Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broomé U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Among authors: broome u. Scand J Gastroenterol. 2001 Aug;36(8):886-90. doi: 10.1080/003655201750313441. Scand J Gastroenterol. 2001. PMID: 11495087

6

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broomé U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E. Boberg KM, et al. Among authors: broome u. Scand J Gastroenterol. 2002 Oct;37(10):1205-11. doi: 10.1080/003655202760373434. Scand J Gastroenterol. 2002. PMID: 12408527

7

The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.

Melum E, Karlsen TH, Broomé U, Thorsby E, Schrumpf E, Boberg KM, Lie BA. Melum E, et al. Among authors: broome u. Tissue Antigens. 2006 Jul;68(1):78-81. doi: 10.1111/j.1399-0039.2006.00604.x. Tissue Antigens. 2006. PMID: 16774544

8

Increased prevalence of primary sclerosing cholangitis among first-degree relatives.

Bergquist A, Lindberg G, Saarinen S, Broomé U. Bergquist A, et al. Among authors: broome u. J Hepatol. 2005 Feb;42(2):252-6. doi: 10.1016/j.jhep.2004.10.011. J Hepatol. 2005. PMID: 15664252

9

Primary sclerosing cholangitis can present with acute liver failure: Report of two cases.

Bergquist A, Glaumann H, Lindberg B, Broomé U. Bergquist A, et al. Among authors: broome u. J Hepatol. 2006 May;44(5):1005-8. doi: 10.1016/j.jhep.2006.01.033. Epub 2006 Feb 28. J Hepatol. 2006. PMID: 16551483

10

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM. Bowlus CL, et al. Among authors: broome u. J Hepatol. 2006 Nov;45(5):704-10. doi: 10.1016/j.jhep.2006.03.012. Epub 2006 Apr 25. J Hepatol. 2006. PMID: 16750586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters